A lack of competitiveness and supportive legislation has combined with soft demand to push firms to sell or close plants ...

The company has massive low-carbon methanol projects in the works in Chile, Uruguay, Brazil, the US, and Tasmania. The cost ...

Over the past week, thousands of employees have been fired across multiple US regulatory and science funding agencies. The ...

These are unprecedented times for US scientists. President Donald J. Trump's administration is enacting sweeping changes, ...

Pembrolizumab is a checkpoint inhibitor that binds to the protein PD-1 on T cells to help them recognize and attack invaders.

Combining machine learning with surface-enhanced Raman scattering spectroscopy makes the analytical tool more powerful ...

AI can deliver huge benefits to chemistry, but some also worry about the turbulence it might bring to the job market ...

The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

Chemical companies in the US and Europe began exiting the pharmaceutical industry in the mid-1990s, when the British firm ICI ...

Ansar Lemon, an engineering PhD student at Harvard University, says the team modeled how the brightness and color of the sky ...

If insulin can’t get out of blood vessels, it can’t act in its target tissues. “Endothelial cells are full of insulin ...

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing ...